Open AccessErratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
Author(s) -
Muhammad AbdulGhani,
Osama Migahid,
Ayman Megahed,
John M. Adams,
Curtis Triplitt,
Ralph A. DeFronzo,
Mahmoud Zirie,
Amin Jayyousi
Publication year - 2017
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc17-er08d
Subject(s) - medicine , pioglitazone , exenatide , metformin , sulfonylurea , type 2 diabetes , diabetes mellitus , insulin , basal insulin , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom